Insulin Pumps Industry Market (China-specific Market Assessment) - Global Forecast upto 2024
- May, 2018
- Domain: Healthcare - Medical Devices
- Get Free 10% Customization in this Report
Overview of the Global Insulin Pumps Market
Infoholic’s market research report predicts that the global insulin pumps market will grow at a CAGR of 9.7% during the forecast period 2018–2024. The major drivers of the insulin pumps market are the increased prevalence of diabetes, growing popularity of advanced insulin pumps, and the introduction of new technologies.
According to the insulin pumps market analysis, North America is set to be the leading region for the insulin pumps market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in patient population and focus toward healthcare infrastructure.
North America is leading with technological innovations, followed by Europe and Asia Pacific. Asia Pacific is expected to witness rapid growth during the forecast period due to increased incidence of diabetes in the region. However, the high cost of infusion pumps, development of oral insulin, and insulin aerosols in the form of inhalers can pose a challenge to the insulin pumps market in future.
The insulin pumps market has the lowest penetration in emerging regions, and most of the vendors are targeting India, Thailand, Indonesia, and Vietnam. These countries are the major revenue contributors in the APAC region. A higher incidence of obesity will fuel the market expansion, which will result in the high prevalence of diabetes. Around 114.1 million people in China are suffering from diabetes (type 1 & type 2), among which type 2 diabetes is more prevalent. China lacks innovative technologies and access to current trends in diabetes management, which further adds to the growth of diabetic population in the region. However, the high cost of insulin pumps, expensive consumables cost, lack of proper reimbursement policies, lack of awareness about insulin pumps in developing countries will have a significant impact on the overall market growth.
Competitive Analysis and Key Vendors
The insulin pumps market is highly fragmented and has immense growth opportunities for vendors, especially in developing regions. The market has the presence of many global, regional, and local players with strong competition among each other.
According to the WHO estimates, the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014. The market for insulin pumps is growing due to increase in the number of diabetes cases among all age groups. The demand for insulin pumps is high due to varied features and functionalities. The insulin pumps market has been segmented into traditional insulin pumps, disposable insulin pumps, smart pumps, insulin reservoirs, insulin infusion sets, and other devices. Diabetes is one of the most prominent non-communicable diseases prevailing globally. According to the seventh edition of IDF Atlas, in 2015, there were 415 million people with diabetes (aged 20–79 years), and the number is expected to reach 642 million by 2040.
Some of the key vendors in the market are:
- Insulet Corp.
- Medtronic Plc
- MicroPort Scientific Corporation
- Hoffmann-La Roche
- Tandem Diabetes Care, Inc.
Segmentation of product type
- Tethered Insulin Pump
- Untethered Insulin Pump
- Implantable Insulin Pump
Tethered insulin pump is dominating with more than 70% of the market share. Tethered insulin pumps have a long flexible tube and are the most common pumps used among diabetic patients. Increasing aging population, rise in prevalence of diabetes, need for early prevention of diseases, and growing awareness about a healthy lifestyle are expected to drive the market growth. The high cost of insulin pumps is the primary concern and challenge to the market. Many insurance providers do not have complete reimbursement for insulin pumps, and the usage of these pumps is subjective to the insurance provider in most of the developed countries. An insulin pump is cost-effective only if it is covered under health insurance.
Segmentation of end-users
The report provides detailed information about the usage and adoption rate of insulin pumps for the treatment of diabetes. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward insulin pumps in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in the insulin pumps market.
1.1 Patient Demographics
1.2 Healthcare Spending in the US
1.3 Definition: Insulin Pump
1.4 Diabetic Overview
1.5 Insulin Pump Definition – Infoholic Research
1.6 Importance of Insulin Pump
1.7 Industry Trends
1.8 Pest Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 China Insulin Pump Market
3.4 Healthcare in China
3.5 Competitive Scenario
3.6 Related Markets
3.6.1 Ultrasound Devices
3.6.2 Medical X-ray Equipment
3.6.3 MRI Equipment
3.7 Porter 5(Five) Forces
4 Market Characteristics
4.2 Insulin Pumps Therapy Advantages
4.3 Insulin Pumps Therapy Disadvantages
4.4 Role of Insulin Pumps in Healthcare
4.5 Market Dynamics
184.108.40.206 Huge Surge in Aging Population
220.127.116.11 Increase in Awareness
18.104.22.168 Increasing Number of Diabetic Patients
22.214.171.124 Rising Incidences of Government Initiatives
126.96.36.199 Technological advances in insulin pump
188.8.131.52 Insulin Pumps replacing traditional Methods
184.108.40.206 Increasing partnership and collaboration activities
220.127.116.11 Focus on early diabetes management
18.104.22.168 Rapid growth in emerging countries
22.214.171.124 High price of latest insulin pumps
126.96.36.199 Unfavorable reimbursement plans
188.8.131.52 Availability of substitutes
184.108.40.206 Competition among major vendors
4.5.4 DRO – Impact Analysis
4.5.5 Key Stakeholders
5 Types: Market Size and Analysis
5.2 Tethered insulin pump
5.3 Untethered insulin pumps
5.4 Implantable insulin pump
6 End User: Market Size and Analysis
6.5 Others (nursing homes and medical offices)
7 Regions: Market Size and Analysis
7.2 North America
7.5 Rest of the World
8 Market Attractiveness
8.1 Market Attractiveness by Products
8.2 Market Attractiveness by End Users
9 Competitive Landscape
10 Product Matrix
11 Vendor Profiles
11.1 Insulet Corp.
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Medtronic Plc
11.2.2 Business Unit
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategy
11.3 MicroPort Scientific Corporation
11.3.2 Business Units
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 F.Hoffmann-La Roche Ltd
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Tandem Diabetes Care, Inc
11.5.2 Business Focus
11.5.3 SWOT Analysis
11.5.4 Business Strategy
12 Companies to Watch For
12.1 Eli Lilly and Company
12.2 Animas Corp.
12.3 Sooil Development Co., Ltd.
12.4 Ypsomed Holding AG
12.5 Valeritas, Inc
12.6 GlySens ICGM
Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.